Monoamine oxidase inhibitors were linked to the highest risk for cardiovascular Standardized MedDRA Queries. Dopamine reuptake inhibition and binding inhibition are linked to antidepressant-related ...

Centanafadine is a serotonin-norepinephrine-dopamine reuptake inhibitor. The two, 6-week, multicenter, double-blind, placebo-controlled trials (Study 1 and Study 2) evaluated the efficacy and safety ...

Dopamine agonists and dopamine reuptake inhibitors (DRIs) appear to have equal efficacy for Parkinson's disease (PD) and motor fluctuations uncontrolled by levodopa. However, some DRIs are more ...

Some people are afraid that taking a medication will change their personality, but most find that medication allows them to take charge of their lives. Medications for mental health conditions fall ...

Medication isn’t the only option for ADHD, but for some, it can be transformative. This piece examines how ADHD can be managed, and benefits and risks to stimulant use.

SAN FRANCISCO — A norepinephrine-dopamine reuptake inhibitor (NDRI) that is in phase 3 development showed promise in changing eating behaviors in adult patients with binge eating disorder (BED) in a ...

Dopamine brings on a surge of pleasure, but too much dopamine in a synapse can ultimately lead to mood disorders and addiction. A recent preclinical study published in The FASEB Journal suggests that ...

Essential for normal central nervous system function, dopamine signaling mediates physiological functions as diverse as movement and lactation. The dopamine transporter (DAT) is involved in ...